Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT01504126 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2019-08-29
Summary
This early phase I trial studies giving propranolol hydrochloride with standard chemotherapy in treating patients with ovarian, primary peritoneal, or fallopian tube cancer. Biological therapies, such as propranolol hydrochloride, blocks certain chemicals that affect the heart and this may stimulate the immune system and allow the chemotherapy to kill more tumor cells.
Conditions
- Fallopian Tube Clear Cell Adenocarcinoma
- Fallopian Tube Endometrioid Adenocarcinoma
- Fallopian Tube Mucinous Adenocarcinoma
- Fallopian Tube Serous Adenocarcinoma
- Fallopian Tube Undifferentiated Carcinoma
- Ovarian Clear Cell Adenocarcinoma
- Ovarian Endometrioid Adenocarcinoma
- Ovarian Mucinous Adenocarcinoma
- Ovarian Seromucinous Carcinoma
- Ovarian Serous Adenocarcinoma
- Ovarian Undifferentiated Carcinoma
- Primary Peritoneal Serous Adenocarcinoma
- Stage II Fallopian Tube Cancer AJCC v6 and v7
- Stage II Ovarian Cancer AJCC v6 and v7
- Stage IIA Fallopian Tube Cancer AJCC v6 and v7
- Stage IIA Ovarian Cancer AJCC V6 and v7
- Stage IIB Fallopian Tube Cancer AJCC v6 and v7
- Stage IIB Ovarian Cancer AJCC v6 and v7
- Stage IIC Fallopian Tube Cancer AJCC v6 and v7
- Stage IIC Ovarian Cancer AJCC v6 and v7
- Stage III Fallopian Tube Cancer AJCC v7
- Stage III Ovarian Cancer AJCC v6 and v7
- Stage III Primary Peritoneal Cancer AJCC v7
- Stage IIIA Fallopian Tube Cancer AJCC v7
- Stage IIIA Ovarian Cancer AJCC v6 and v7
- Stage IIIA Primary Peritoneal Cancer AJCC v7
- Stage IIIB Fallopian Tube Cancer AJCC v7
- Stage IIIB Ovarian Cancer AJCC v6 and v7
- Stage IIIB Primary Peritoneal Cancer AJCC v7
- Stage IIIC Fallopian Tube Cancer AJCC v7
- Stage IIIC Ovarian Cancer AJCC v6 and v7
- Stage IIIC Primary Peritoneal Cancer AJCC v7
- Stage IV Fallopian Tube Cancer AJCC v6 and v7
- Stage IV Ovarian Cancer AJCC v6 and v7
- Stage IV Primary Peritoneal Cancer AJCC v7
Interventions
- DRUG
-
Undergo standard chemotherapy
- DRUG
-
Propranolol Hydrochloride
Given PO
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
- PROCEDURE
-
Therapeutic Conventional Surgery
Undergo surgical resection
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Sprint for Life
collaborator UNKNOWN -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Lois M Ramondetta · M.D. Anderson Cancer Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-09
- Primary Completion
- 2019-08-15
- Completion
- 2019-08-15
Countries
- United States
Study Locations
More Related Trials
-
Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00006114 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of HPN424 in Patients With Advanced Prostate Cancer
NCT03577028 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
NCT00108290 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005847 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
NCT00017563 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer
NCT06029036 ·Status: RECRUITING ·Phase: PHASE2
-
Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer
NCT00651326 ·Status: TERMINATED ·Phase: PHASE3
-
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
NCT00004124 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
NCT04848519 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer
NCT00134706 ·Status: COMPLETED ·Phase: PHASE2
-
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
NCT00134056 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
NCT00030654 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy
NCT00407251 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
NCT03436654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection
NCT01832259 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer
NCT01230866 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003734 ·Status: UNKNOWN ·Phase: PHASE3
-
CCI-779 in Treating Patients With Prostate Cancer
NCT00012142 ·Status: COMPLETED ·Phase: PHASE2
-
Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer
NCT01828476 ·Status: TERMINATED ·Phase: PHASE2
-
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
NCT01603420 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00028769 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
NCT05100472 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
NCT00077402 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
NCT03042468 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
NCT04729114 ·Status: RECRUITING ·Phase: PHASE1